secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001636422-23-000129
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst beats Q3 guidance; raises FY2023 revenue outlook; Adj. EBITDA positive
--------------------------------------------------------------------------------

- Q3 total revenue $73.8M (+8% YoY), above guidance midpoint; net loss $22.0M vs $45.7M loss in Q3 2022.
- Adjusted EBITDA $2.0M (improvement from -$4.6M YoY), also above guidance midpoint of $1.25M.
- Raised FY2023 revenue guidance to $291M-$296M from $290.5M-$295.5M; reiterated Adj. EBITDA $10M-$12M.
- New DOS client: Accountable Health Partners (~400k patients); Q4 expected to be a large bookings quarter.
- Mid-term targets: revenue reacceleration in 2024, 10% Adj. EBITDA margin in 2025, long-term 20%+ growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/0001636422-23-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/hcat-20231102.htm
  HTML page:      https://secwatch.observer/filing/0001636422-23-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer